throbber
12864
`
`Biochemistry 1993, 32, 12864-12874
`
`Mechanism for the Rotamase Activity of FK506 Binding Protein from Molecular
`Dynamics Simulationst
`
`Modesto Orozco, I Julian Tirado-Rives, and \Villiam L. Jorgensen•
`
`Department of Chen1istry, Yale University, New Haven, Con11ecticu1 06511-8118
`Received June 4, 1993; ReviJed J.fanuscript Received Septe1nber I 3, J 993*
`
`ABSTRACT: Molecular dynamics (MD) and free energy perturbation (FEP) methods are used to study the
`binding and mechanism of isomcrization of a tetrapeptide (AcAAPFNMe) by FK506 binding protein
`(FKBP). Detailed structures are predicted for the complexes of FKBP with the peptide in both ground-state
`and transition-state forms. The results support a mechanism of catalysis by distortion, where a large
`number of nonbonded interactions act together to stabilize preferentially the twisted transition state. The
`two most important groups for the catalysis are suggested to be Trp39 and Asp31, but several other groups
`are identified as directly or indirectly involved in the binding and catalysis. However, the structural results
`do not support the notion that the keto oxygen of the immunosuppressive agents FK506 and rapamycin
`mimics the oxygen for the twisted peptide bond in the FKBP-transition-state complex.
`
`The isomerization of peptidic bonds is a difficult process
`with free energy barriers typically being 15-20 kcal/mot
`(Drankenberg & Forsen, 1971; Larive & Rabenstein, 1993).
`Most peptides correspond to secondary amides and are found
`exclusively in the trans conformation, which is about 2.5 kcal/
`mol more stable than the cis (Drankenberg & Forsen, 1971 ).
`However, the tertiary nitrogen in prolyl residues allows the
`coexistence of cis and trans isomers in proteins, which may
`require interconversion during protein folding. Considering
`the difficulty of this reaction, and the need for efficient folding
`mechanisms in vivo, the existence of enzymes which catalyze
`the isomerization of prolylpeptides (peptidylprolyl isomerases
`(PPls)) is not surprising. PPis were first characterized by
`Fischer and co-workers (Fischer et al., 1984), and since then
`different studies have demonstrated that these enzymes
`catalyze the cis....,.. trans ison1erism of prolylpeptides during
`the folding of various proteins (Fischer & Bang 1985,
`B~chinger, 1987; Lang et al., 1987; Jackson & Fersht, 1991).
`The interest in two PPis, FKBP (FK506 binding protein)
`and cyc!ophilin, increased dramatically after the discovery
`that they are receptors for the immunosuppressant agents
`FK506 (Harding et al., 1989) and cyclosporin (Fischer et al.,
`l 989a; Takahashi, et al., 1989). Particularly, FKBPwasfound
`to be the receptor for a family of immunosuppressant drugs
`which includes FK506, rapamycin, and ascomycin. It was
`demonstrated that the binding of the drugs to the protein
`yields con1plexes which inhibit T-cell activation (see Rosen
`& Schreiber, 1992).
`FKBP is a small, and highly conserved cytosolic protein,
`which was isolated and purified by Schreiber and co-workers
`(Harding et al., 1989), who also cloned the protein (Standaert
`et al., 1990). and determined the 3-D structure in solution
`(Michnick et al., 1991) and in the crystal (van Duyne et al.,
`1991). Actually, 3-D structures of the protein as well as of
`the protein bound to FK506 (van Duyne et al., 199la),
`rapamycin (van Duyne et al .. 1991b), and ascomycin (Mead(cid:173)
`ows et al., 1993) are available. The protein's structure features
`
`'This work was supported by NIH Grant 01132136 and a fellowship
`from the Fullbright Foundation,
`•To whom oorrespondence should be addressed.
`I On lelve from the Departmc:nt de Bioqufmic.a, Facultat de Qui mica,
`Universitat de Barcelona, 1fartf Franqu~ I, Bar«lona 08028, SPAIN.
`•Abstract published in Advance ACS Abstractr, November I, 1993.
`
`a five-stranded antiparallel f3 sheet and a short amphipathic
`a helix, which partially covers one face of the f3 sheet. The
`active site, defined as the region where the protein binds the
`drugs, is located between the a helix and the {3 sheet in a
`hydrophobic pocket for med by the side chains of Trps9, Tyr26,
`Phe45, Phe36, Phe~9, nes6, Tyrs2, and Va1ss.
`Both FK506 and rapamycin bind to FKBP as surrogates
`of prolylpeptides inhibiting the PPI activity (Schreiber, 1991;
`Rosen & Schreiber, 1992). The low Ki and the presence of
`a C9-keto oxygen orthogonal to the pipccolinyl ring suggest
`that both drugs interact with FKBP as n1imicsof the transition
`state for cis- trans isomerization. The fact thatcyclosporin,
`a potent imn1unosuppressant drug, was a powerful inhibitor
`of the PPI activity of cyclophilin led to the speculation that
`the immunosuppressant effects of these drugs were associated
`with their inhibition of PPI activity (see Rosen & Schreiber,
`1992). This attractive hypothesis was ruled out by two
`observations: (i) rapamycin and FK506 have very different
`mechanisms for immunosuppressant activity, although their
`inhibition of PPI activity is similar (Bierer et al., 1990a), and
`(ii) the analog 506BD is a strong inhibitor of FKBP but is not
`an in1munosuppressant (Bierer et al., 1990b). Accordingly,
`the relationship, if any, between the PP! and immunophilin
`activities of FKBP and cyclophilin ren1ains to be determined.
`The mechanisms for the PPI action of the immunophilins
`are also obscure. Fischer and co·workers (Fischer et al.,
`l989b) proposed a mechanism based on the formation of
`covalent adducts between the peptide and protein. Kofron et
`al. (1991) suggested an alternative mechanism in which the
`protonation of the proline nitrogen would facilitate the
`isomerization process. Other authors (Albers et al., 1990;
`Harrison & Stein, 1990; Park et at., 1992; Rosen & Schreiber,
`1992) have suggested a mechanism based on the preferential
`stabilization of the transition state by non bonded interactions
`(catalysis by distortion). However, the Jack of a structure for
`a complex between an im1nunophilin and a peptide has limited
`the experimental characterization of the rotamase mechanism.
`In this paper, we present a molecular dynamics (MD) study
`on the mechanism of peptide isomerization catalyzed by FKBP.
`Kinetic measurements have been made for els _...... trans
`isomerization of tetra peptides (Fischer et al., 1989; Albers et
`
`0006· 2960 /93/0432·12864104.00 /0
`
`© 1993 American Chemical Society
`
`Roxane Labs., Inc.
`Exhibit 1018
`Page 001
`
`

`
`Mechanism for Rotamase Activity
`
`Biochemistry, Vol. 31. No. 47, 1993 12865
`
`Table I: Force Field Parameters for the Ala3-Pro4 Peptide Bond•
`bond or angle
`equil. value
`force constant
`lOO
`C-NIV
`l.39
`C-NIV-CH
`5
`l 15.0
`C-NIV-CQ
`115.0
`114.0
`CH-NIV-CQ
`
`dihedral angle
`Ca(A3)-C(A3)-N(P4)-Ca(P4)
`O(A3)-C(A3)-N(P4)-Ca(P4)
`C(A3)-N(P4)-CD(P4)-Ca(P4)
`Ca(A3)-C(A3)-0(A3)-N(P4)
`
`equil. value
`120/0
`-"0/180
`-t20/180
`tS0/180
`
`force constant
`200
`200
`too
`lOO
`
`q (cis)
`q (Twhted)
`atom
`0.340
`Ca(Al)
`0.200
`0.437
`C(A3)
`0.500
`O(AJ)
`--0.457
`-0.500
`--0.570
`N(P4)
`--0.570
`Ca(P4), CD(P4)
`0.225
`0.285
`a The atom typeN\V correopondi to N(Pro4) of the twisted conformer;
`other atom types are from the standard A1iBER/OPLS force-field
`(Weiner et al., 1984; Jorgensen & Tirado-Rives, 1988), Distances are
`in A, angles in deg, chargei in electrons, and force oonstants in kcal/mo!
`Al, or kcal/mo\ rad 2, The dihe-Oral parameters are used a$ constrains
`to keep the cfs or rwfs1ed conformation. Standard AMBER torsional
`parameters for the Ala3-Pro4 bond are removed.
`
`twisted amide bond were derived from recent calculations on
`twisted dimethylacetamide (see Table I and Duffy et al.
`(1992)), These charges correctly reproduce properties of
`amides in solution, including free energies of hydration
`(Jorgensen & Tirado-Rives, 1988; Duffy et al., 1992).
`The crystal structure of FKBP bound to rapamycin (van
`Duyne et al., 199lb) was used as a starting point for the
`calculations. First, the peptide in the twisted form was overlaid
`on rapamycin. Theconforn1ation of the peptide was modified
`by rotation around single bonds to obtain the best fit with
`rapamycin and to reproduce well the environment of analogous
`hydrogen bond donor and acceptor groups. Once a suitable
`conformation of the peptide was obtained, the drug was
`removed, yielding a protein-peptide complex in which the
`peptide not only reproduces the general shape of rapamycin
`but also has a similar pattern of hydrogen bonds with the
`binding pocket.
`The protein-peptide model was solvatcd with a sphere of
`23·A radius containing TIP3P water (Jorgensen et al., 1983)
`centered on the center of mass of the peptide. This led, after
`removal of water molecules with unreasonably short contacts,
`to a salvation sphere with 1002 water molecules. A soft
`harmonic term with a force constant of 1.5 kcal/(mol A2) was
`used to retreive water molecules drifting beyond the boundary
`of the sphere. The resulting system is shown in Figure 2,
`where it is clear that the sphere of water provides extensive
`hydration of the binding site for the MD calculations. The
`solvated system was then divided into two regions: (i) an
`inner part, which includes the peptide, the water, and all
`residues which have at least one atom closer than 12 A to any
`atom of the peptide, and (ii) an outer part, which contains the
`rest of the protein. The first part includes 78 residues of the
`protein and was free to move in all minimizations and MD
`simulations, while the outer part with 25 residues was kept
`rigid in all calculations, This initial system was then prepared
`through 2000 steps of energy minimization (500 where the
`peptide and the protein were kept rigid, 500 where only the
`peptide was fixed, and 1000 where the entire system was
`minimized), and 40 ps of MD for heating from T == 198-298
`K and equilibration. The final equilibrated structure was
`used to run 500 ps of constant temperature MD at 298 K. The
`
`Pto.f
`Ala.3
`FIGURE l: Structure and nomenclature of the peptide used in the
`simulations.
`
`al., 1990i Harrison & Stein, 1990; Kofron et al., 1991; Harrison
`& Stein, 1992: Park et al., 1992). Consequently, structures
`for the complexes of a tetrapeptide with a cis peptide bond
`and of its transition state were sought and obtained here.
`Support for the model includes free energy results for mutation
`of the P 1 residue. Specific interactions responsible for selective
`stabilization of the transition state are identified. The model
`clarifies in detail the mechanism of rotamase action and is
`open to experimental testing, The binding insights should
`also be useful in the design of high-affinity ligands for FKBP
`with potential imn1unosuppressive activity.
`
`COMPUTATIONAL METHODS
`
`A peptide with the sequences Ace-Ala-Ala-Pro-Phe-Ame,
`where Ace (acetate) and Ame (methylamide) are the N- and
`C-terminal groups, was used to mimic the natural substrate.
`Figure 1 shows the structure and related nomenclature; in the
`following, plain numbering is used for the peptide residues
`and superscript numbering is used for protein residues. This
`sequence was selected because is resen1bles closely the synthetic
`peptides (Suc-Ala-X-Pro-Phe-pNA) used to nleasure the
`activity of PP!s (Fischer et al., 1989; Albers et al., 1990;
`Harrison & Stein, 1990; Kofron et al., 1991; Park et al., 1992).
`The peptide was built in both cis and twisted conformations
`around the Ala3-Pro4 peptidic bond, The peptide in the els
`conformation is used as a model of the substrate, and the
`twisted conformation, as a model for the transition state.
`The molecular dynamics calculations were carried out with
`the AMBER program, version 4.0 (Pearlman et al., 1991).
`The AMBER/OPLS force field (Weiner et al., 1984;
`Jorgensen & Tirado-Rives, 1988; Jorgensen & Severance,
`1990) was used to describe both the peptide and the protein
`interactions; the only modifications (see Table I) were for the
`peptidic bond Ala3-Pro4, where the torsional barrier and
`improper torsion at nitrogen were removed (in both planar
`and twisted conformations), and the bond lengths and angles
`at N(Pro4) were assigned to average values for planar and
`twisted amides (Duffy et al., 1992). The stretching and
`bending parameters related to N(Pro4) were reduced in order
`to allow the peptide to accommodate easily to the protein
`environment. Four constraints were used to guarantee that
`the Ala3-Pro4 peptidic bond stayed in the cis or twisted
`conformation. The same force constants were used for both
`conformers in order to make comparable the Hamiltonians
`for the els and twisted peptides (Table I). The contribution
`of these constraints to the total energy was not included in any
`of the simulations.
`Standard OPLS Lennard-Jones parameters were used for
`the cis and twisted structures (Jorgensen & Tirado-Rives,
`1988;Jorgensen & Severance, 1990). Standard OPLS charges
`for amides were also used to describe the planar structure
`(Jorgensen & Tirado-Rives, 1988), while the charges for the
`
`Roxane Labs., Inc.
`Exhibit 1018
`Page 002
`
`

`
`12866 Bioche111istry, Vol. 32, fi'o. 47, 1993
`
`Orozco ct al.
`
`\
`''
`
`FIGURE 3: Tl1crmodynarnic cycle used to determine the .6Li.G' of
`isomeri1ation lxtwcen the Ala and Gly peptide~. Dark lines arc the
`peptide and light lines arc !he r.ipamydn molecule.
`
`,\jN] . .'i.\
`
`?J.G = L -kTln (exp(-(V,i.,+r}~
`
`),~o
`
`V,..)/k'/1)~1
`
`(I)
`
`wide sampling windows of 5 ps each (2 ps of equilibration and
`3 ps of averaging) for a total of 205 ps for each mutation. The
`entire peptide was considered as the perturbed group in the
`n1utation; not only the intergroup interactions, but also all the
`intragroup nonbondcd interactions (including 1-·4) were
`considered in the evaluation of the free energy changes. \Ve
`had dctern1ined in pilot calculations th al the explicit inclusion
`of bonded contributions in the free energy calculation led to
`increased noise in the final free energies, but did not alter
`significantly the final results. The averaging in eq I was
`performed by lvt D simulations at constant T = 298 K. where
`T is the temperature, k is Bohz111ann's constant, ,\ is the
`coupling paramder, which controls the evolution or the Ala
`--.. Gly mutation, and V~ is the potential energy of the system.
`A similar simulation was performl'd to determine whether
`or not the structure of the ciJ peptide was able to c.xplain
`experimental binding data (Parker ct al., 1992). Thus, the
`difference in free energy of binding between Ala and Gly
`(cis)peptidcs (0.il.Gr.;r...i) was determined as the difference
`between the free energy changes in the mutation Ala-· .. G\y
`in water (l!.Gm~t"~ 1a), and in the protein comple.\ (~Gm~t''r«).
`In order to coniputc ilGmut"• 1n the Ala (cis)peptide in the
`conformation adopted inside FKBP at the end of the J\·ID was
`introduced into a cubic box (l'dgc ~~ 30 A) of TIPJP water.
`The closest water n10\cculcs wen.~ removed to yield toa system
`with 807 water molecules. The system was minimi1.ed for
`3000 cycles (2000 with the pl'ptide fixed and 1000 with the
`entire svstcm free). The systc1n was heated from 198 to 298
`K duri1;g 5 ps of NVT ~tD (during the first 3 ps only the
`water was allowed to n1ove), and equilibrated during 20 ps of
`NPT :0..tD (T = 298 K; P = I atm). The free cnergr change
`for the Ala - ~ Gly mutation was computed using 41 double(cid:173)
`widesampling windows of 2.5 ps ( 1.25 ps of equilibration and
`1.25 psof averaging) for a total of 102.5 ps. Periodic boundary
`conditions were used in all the simulations. All the re1naining
`technical details of the sin1ulations were identical to tho-;e
`noted above for the peptide-protein cmnplexc.s.
`
`RESULTS
`
`Transition-State S'rn1ctrtr1'. The strt1L'turc of the twisted
`transition state snndel. which w;is obtained after the fitting,
`npti1ni1ation, and c4uilibratio11 prot:css rcsl'rnbks the general
`
`F!GURP. 2: FKBP-pcptidc complex inside the 23-A sphcr.:: of water
`used in the l\1D simulations.
`
`integration step was 0.002 ps. and the coordinates were stored
`every 0.2 ps;. SJIAKE (Ryckacrl ct al., 1977) was used to
`maintain all bonds kngths al their cquilibriun1 values. A
`nonbonded spherical cutoff of 8 A and a residuc-b;1scd
`non bonded list, updated every 25 integration steps, were used.
`The structure at r = 100 ps. was used to generate the cis
`pcptide--protein complex. The change between 1wis1nl and
`cis peptides was done in si.x steps with the angles of the
`constraints and the charges gradually modified from fll'istcd
`to cis values (Table I). After each change, the peptide alone
`wa.;; optirni1.ed i111·an10 for 100 cycles; harntonic constraints
`were us~'d to guarantee that most of thcconfonnational changl'~
`would occur mainly in the Ala3--Pro4 urea. This si1nple
`procedure 1nimics a fast change from twisted to cis, and we
`found it to be superior to other 1nethods such as stepwise
`rotation for the full protein- peptide systen1 and si111ulated
`annealing.
`The cis peptide was then placed inside the binding pocket
`or the solvatcd protein occupying the san1c location as the
`1wisted conrorn1er. The S)S!Cm was opti1nized, hl'atcd, and
`equilibrated during 40 ps using a procedure analogous to that
`described above. A 500·ps !vtD trajectory was then run for
`It should be notl'd that the cis and twistt'd
`the cl-~ system.
`systems contain thcsa1ne number of ato1ns, identical definition
`oft he hydratinn shell, identical partitioning between the inner
`and outer regions, and, except for the charges, the san1e
`Ha1niltonian.
`Frceenergycalculations were used to predict the difference
`in isomerization rate between two peptides, Acc·Ala-Ala(cid:173)
`Pro· Phe·A1ne and Ace-Ala-Gly-Pro· Phe·Ame, for co1nparison
`with experi1nental data on the corresponding Suc-Ala-X-Pro·
`Phc-pNA peptides (Albers ct al., 1990; Harrison & Stein,
`1992; Park et al.. 1992). The thcr1nodyna1nic cycle in Figure
`3 was utilized to obtain the change inf rccenergiesof activation.
`The free energy changes for the AlaJ ____,,. GlyJ 1nutations was
`computed by statistical perturbation theory ac-cording to eq
`I (Zwa111.ig, l9S4). The.sc 1nutations were started with the
`structures and ve]qcities of the cis and !wisted systcnv~ at the
`end of the ~·1 D runs. The \;akulations were done in 41 double-
`
`Roxane Labs., Inc.
`Exhibit 1018
`Page 003
`
`

`
`Mechanism for Rotamase Activity
`
`Biochemistry, Vol. 32, No. 47, 1993 12867
`
`FIGURE 4: Superposition of the structures of bound rapamycin and the twisted peptide afler the e<J,uilibration.
`
`ALA3
`
`140.0
`
`340.0
`240.0
`l(ps)
`
`440.0
`
`540.0
`
`PHE5
`
`ALA2
`
`0
`
`" Vi
`
`120.0
`
`6-0.0
`
`·60.0
`
`·120.0
`
`-180.0 ~-~--~--~--~--~
`40.0
`140.0
`240.0
`340.0
`440.0
`540.0
`t(ps)
`
`PR04
`180.0 ~-~--~--~--~--~
`
`;1
`VJ
`
`120.0
`
`60.0
`
`0.0
`
`·60.0
`
`·120.0
`
`120.0
`
`60.0
`
`·60.0
`
`·120.0
`
`·60.0
`
`·120.0
`
`·180.0 ~-~~-~~-~--~--~
`40.0
`140.0
`240.0
`340.0
`440.0
`540.0
`l(ps)
`
`·t80.0 --~--~--~--~~---'
`140.0
`240.0
`340.0
`440.0
`540.0
`40.0
`l(ps)
`
`F!OURE 5: Dihedral angle histories for the twisted peptide.
`
`structure of rapamycin, as shown in Figure 4. The main chain
`of both molecules overlaps well, and the H·bond donors and
`acceptors are also in proximal positions. In particular, O(Ala3)
`is placed very close to the keto oxygen of rapamycin, and the
`Pro ring shares the space of the pipecolinyl ring.
`Analysis of the 500 ps trajectory shows flexibility in the
`peptide, especially for the side chain of Phe5 and in the Ala3-
`Pro4 region. The histories for the main chain dihedral angles
`shown in Figure 5 reveal that most movements are short range
`oscillations, which do not lead to dramatic changes in the
`structure. However, there is also a systematic movement
`
`occurring for the Ala3-Pro4 region in the 80-120 ps period,
`which leads to a significant change in the relative orientation
`of the peptide inside the protein, as shown in Figure 6, The
`conformation of the 60 and 540 ps structures are similar, as
`noted in Figures 5 and 6 with a general .. turn" topology
`stabilized by one or two intrachain hydrogen-bonds. The
`largest differences between the 60 ps and 540 ps structures
`are in the positioning of the praline ring and Ala3-Pro4 with
`respect to the binding site (see Figures 6 and 7). The reduction
`in Y, for Ala3 after 60 ps secures the hydrogen bonds for the
`turn structure and leads to better possitioning of the Ala3
`
`Roxane Labs., Inc.
`Exhibit 1018
`Page 004
`
`

`
`12868 Biochenlisrry, Vol. 32, 1Vo. 47, 1993
`
`Orozco et al.
`
`T\vistcd 60 ps
`
`O(Al:i.1)
`
`'l\vistcd 540 ps
`
`FIGURE 6: Representation of the structure adopted inside the binding site by rap..1111ycin. and the tw1:~1edpcptidc at 60 and 540 ps, A common
`reference axis was used to orient the molecules.
`
`Rapainycin
`
`I
`
`,
`
`,:!ftrtiu",:
`
`-
`
`'Ill
`
`L ~: TI<'l
`,;,
`
`_ rmn
`
`~ ~
`
`,
`
`F
`
`>
`
`~
`
`"
`
`FIGURE 7: The twisted peptide bound to the active site of FKHP.
`carbonyl group with respect to the Asp17 side chain (sec below).
`The distances for key interactions arc shown in Figure 8.
`A hydrogen bond exists between the Asp37 side chain and the
`an1ino groups of Ala2 and often Ala3, which arc proximal
`(Figures 6 and 7). Two intrachain hydrogen bonds arc also
`
`con1n1on: Arnc6-Acel, and Phe5-Ala2, which stabilize the
`turn structure. Another interesting interaction is the close
`contact (ca. 2.0 A) between the atnidc hydrogen of Phc5 and
`the N of Pro4. There arc no hydrogen bonds between the
`oxygen of AlaJ and the protein. The analysis of Figure 8
`
`Roxane Labs., Inc.
`Exhibit 1018
`Page 005
`
`

`
`:Vlcchanism for Rotamast: Activity
`
`1Jiochen1istry, Vol. 32, Nv. 47, l'J'J3
`
`12:-:69
`
`.
`
`6.0 ~. d{O(P<)·:;~I~))
`I
`~ 5.o
`g 4.0
`.~ 3.0
`u
`2.0
`
`1.0 -
`40.0
`
`360.0
`200.0
`l(p!.)
`
`520.0
`
`6
`
`5.0
`
`-U
`
`I
`
`i
`
`'
`i
`
`I
`
`•
`'
`
`d{0{3)--002(037))
`
`6.0
`
`I
`
`5.0
`~
`~ 4.0
`g
`~ 3.0
`2.0
`_______ .... __ , __ __._--...........L
`1.0
`520.0
`40.0
`200.0
`300.0
`l{ps)
`
`d{Hll{A2)-002{037))
`6.0 ~~---,·-·------,---------r
`
`1.0
`40.0
`
`60 r_01~C{A3)-00>(0J1))
`
`I
`
`'
`
`'
`
`__ 5.0
`~ '
`g 4.0
`
`~ 3.0
`u
`
`2.0
`
`1.0 - ·
`3f.i0.0
`40.0
`200.0
`t(ps)
`
`52'0.0
`
`60
`
`d(Htl(A3)-002(037tu)) •
`
`50
`
`I::, i~
`'0 ~ 0-~---- '
`
`40 0
`
`3$).0
`200.0
`1(ps)
`
`S?\l 0
`
`.0 '~d(H>l~(Amo)-O(A~))
`" ¢ 4.0
`~ 3.0
`~·: -~-•---~
`
`40 0
`
`-
`
`520.0
`
`--------~--
`520.0
`360 0
`200.0
`200.0
`300.0
`l(ps)
`1{ps)
`F1GCR1; 8: Histork-s for ~elected interatomic distnnrcs during the MD ~imulation for the twi.11n/ peptide.
`
`reveals that thc-1noverncnts during the 80·-120 ps period have
`two major consequences: first the hydrogen bond b1:tween
`llcl6 and Pro4, which ntimics one of the hydrogens bonds in
`the crystal structure of the FK DP- rapamycin co1npkx is lost,
`and second, the intrapeptide hydrogen bond between Amc6
`and Ace\ is forntcd. Two kss dramatic, but particularly
`significant changes, are in the distance,~ between the Asp 37
`side chain and the C"·=O moiety of Ala3.
`In the starting
`confoT1nation, one of the negatively charged oxygens of Aspn
`is about 3.6 A from ()(AlaJ_) and 4.0 A from C(AlaJ), while
`in the final conforination these distances arc around 4.7 and
`J.9 A. respectively. Thus, the conformational change in the
`80-120-ps period transforms a clearly bad charge-dipole
`contact into a n1uch 111orc favorable one. It is also notable
`that after the confonnational change, lhe position of the
`carbonyl oxygen of AIClJ is 111on• si111ilar lo that of the a111ide
`oxygen rather than the keto oxygt'll of rC1pa1nyci11.
`The movc1nent of the 0(Ala3) fron1 the starting to the final
`conforn1ation leads to a n1odcst reduction in the nun1bcr of
`aryl interactions (a contact O(Ala3)-H(aromatic) is con·
`sidercd as an aryl interaction when the Q ... H distance is less
`than 3.2 t\) between 0(Ala3) and lhc aro1natic side chains
`of Phcl6, l'he99 , Tyr16, and Tyr~2 frmn 2.6 to 2.0. Analysis
`of the hydration of the peptide used a gcontetrie definition of
`a hydrogen bond H'quiring an N ... 11 or Q ... J-1 distance less
`than 2.5 A, and a donor- hydrogen -acceptor angle between
`!20 and !80°.
`\Vith this definition, there arc initially 5.4
`waters hydrogen bonded to the peptide on average. Thi~
`number increases to 5.8 in the !a~t 240 ps of the trajectory.
`One water is bound to O(Ala2). 1.3 to O(Accl), and 1.5 to
`0(l'he5 ): however. the latter's intrapeptidc hydrogen bonding
`partner, the amino group of Amc-6, is hydrogen bonded to a
`water only 10<,{; of the tin1e. O(Pro4) is not solvent exposed
`in thestartingconfonnation where it is H·bonded to llc~ 1'. but
`in the final part of the trajectory (I DO-~ 540 ps) it is hydrogen
`bonded to an average of I, I water n1nleculcs. Finally, ()(Ala3)
`is in a purely hydrophobic place during the first 320 ps of the
`trajectory, but at this P'-lint, it captures a water molecule,
`which remains hydrogen bonded during 809(.of the remaining
`time as in Figure 7 (an averageof0.4 water is bound toO(AlaJ}
`when the complete trajectory is considered).
`
`0{/\l•l)
`
`Cis 5-10 ps
`FIGURE 9: Reprc.>cntation of the conformation adopted in<;idc the
`active site by the cis peptide. Only the structure at the end of the
`~to run is shown, since no major changes occur for the ds peptide
`during the ~imulation.
`
`The last step in the analysis of the protein-peptide
`interactions was identifying water bridges co1111ccting polar
`groups of the peptide and the protein. There is a water bridge
`between O(Phe5) and the carbonyl of Ulu 54 during 55o/r, of
`the time, 1nintkking another one of the hydrogen bonds in the
`FKilP-rapa1nycin structure. A water bridge is also detected
`43~{> of the time between O(Ala2) and llis~ 7 , and one exis1s
`40'J, of the time in the l 20--J20-ps period between O(Pro4)
`and Tyr 82 . The latter bridge is Josi in Lhc final part of the
`i\'1[), when the watt:r on ()(/\.la3) rnakcs a bridge Ill the
`hydroxyl group of Tyr~2 during 80',~, of the time (Figure 7).
`Ci.1 Co11fon11atio11. The d.t !Onn of the bound peptide also
`has a turn structure, with obvious similaritic .. ~ to the structures
`of rapan1ycin and the fll"iHcd peptide ( Fi1:ure 9). The position
`of the peptide in the binding site is very si1nilar to that of
`rapamycin, wi1h the proline ring replacing the plpet:olinyl
`ring. The t"l.ID provides significant sampling of the config·
`urational space of the peptide, but nosystcntalicchangcs occur,
`as evident in the distributions of rnain chain dihedral angles
`shown in Figure IO. Key interactions arc indicated in Figures
`11 and 12. Thus, the AspH side chain is again hydrogen
`bonded to the a1nino group of A!a2, and often to the a1nino
`group of AlaJ. I lydrogcn bondsa!so form ocasiunally between
`
`Roxane Labs., Inc.
`Exhibit 1018
`Page 006
`
`

`
`12870 Biochemistry, Vol. 32, No. 47, 1993
`
`ALA2
`180.0 ~--------------
`
`' .,
`
`VI
`
`120.0
`
`60.0
`
`-60.0
`
`·120.0
`
`Orozco et al.
`
`ALA3
`
`60.0
`
`' " VI
`
`0.0 f - - - - - - - - - - - - - -1
`
`·60.0
`
`-120.0
`
`·180.0 ~-~--~--~--~---'
`40.0
`140.0
`240,0
`340.0
`440.0
`540,0
`t(ps)
`
`-180.0 ~~~--~--~-~~--~
`40,0
`140.0
`240.0
`340.0
`440.0
`540.0
`t(ps)
`
`PR04
`
`PHE5
`180.0 ~----------~--~
`
`120.0
`
`60.0
`
`-60.0
`
`·120.0
`
`120.0
`
`60.0
`
`0.0
`
`·60.0
`
`-120.0
`
`' " v•
`
`-180.0 '----~--~-~--~--__,
`40,0
`140,0
`240.0
`340.0
`440.0
`540.0
`t(ps)
`FJOURE 10: Dihedral angle histories for the els peptide.
`
`-160.0 ~-~--~~-~-~---'
`40.0
`140.0
`240.0
`340.0
`440.0
`540.0
`t(ps)
`
`)
`
`..I -t
`
`FrOURE 11: The els peptide bcund to the active site of FKDP.
`NH( Ame) and O(Ala2) and between NH(Phe5) and O(Ala2).
`Other H-bonds (not shown in Figure 12) that are present
`some of the time are between NH(PheS) and the imidazole
`ring of His!7 and between NH(Ame) and O(Pro4). A
`hydrogen bond exists between O(Ala3) and the hydroxyl group
`of Tyr26 only during short periods of time, for instance in the
`160-180-ps period, but most of the time this H-bond is not
`present. It is very interesting to look at the relative positions
`of As pH with respect to the carbonyl group of Ala3; the OD2-
`0(Ala3) distance is around 3,3 A, and the OD2-C(Ala3)
`distance is about 4.0 A. These reveal a repulsive charge(cid:173)
`dipolecontact, which contrasts the favorable interaction found
`
`for the transition state. Intrapeptide hydrogen bonds that are
`present in the twisted conformation, but are not present in the
`els structure are between NH (Phe5) and N(Pro4) and between
`NH(Ame) and O(Ace).
`The carbonyl oxygen of Ala3 is near the aromaticsidechain
`of Phe~ and Tyr26 (Figure 11); the average number of aryl
`interactions is 1.2 for this oxygen, which is ca. 1 less than in
`the twisted conformation. The els peptide is well hydrated,
`with an average of 5.0 waters hydrogen bonded (0.4-0.8 lcss
`than in the twisted structure). A detailed analysis of the
`hydration shell shows that the oxygens of Ace and PheS are
`the best hydrated, with an average of 1.9 and 1.8 water
`
`Roxane Labs., Inc.
`Exhibit 1018
`Page 007
`
`

`
`Mechanism for Rotarnase Activity
`
`d{HN(F5)-0(Af))
`6.0 ~----~-~
`
`Biochemistry, Vol. 32, No. 47, 1993 12871
`
`d(HN(.A.2)-002(03?))
`
`d(HN(A3)-002{037})
`6.0 ~-~-~--~
`
`"'-4.0
`
`5.0 <
`.~ 3.0
`
`'ti 2,0
`
`1.0 ~-~--~-~
`40.0
`200.0
`380.0
`520.0
`t{ps)
`
`1 ·~0~.0--200~.o--300~·~"--,~20.o
`t{pa)
`
`d(0(3)-002(037))
`
`d(C{.A.3)-002(037})
`
`6.0
`
`5.0 < I 4.o
`
`~ 3,0
`2.0
`
`6.0
`
`5.0
`
`g
`~ 4.0
`.i 3.0
`
`2.0
`
`520.0
`
`d(HN(""")--OiA'))
`
`6.0
`
`5.0
`g
`§ •.o
`~ 3,0
`v 2.0
`
`6.0
`
`g
`
`ro
`
`.'ti 3.0
`'ti 2.0
`
`360.0
`200.0
`t{ps)
`
`1.0
`40.0
`
`360.0
`200.0
`t(p•)
`
`520.0
`
`1.0
`40.0
`
`360.0
`200.0
`1(p•)
`
`520.0
`
`F10URE 12: Histories for selected interatomic distances during the dynamics for the els peptide.
`
`molecules bound. The oxygens of Pro4 and Ala2 are less well
`solvated with 0.5 and 0,7 water molecule bound on average.
`The amino group of Ame is hydrogen bonded to a water only
`10% of the time. O(Ala3) which is hydrogen bonded to a
`water molecule in the last part of the MD for the twisted
`conformer, is not solvated in the els conformation. Three
`water bridges exist sporadically; the most common involve
`Glu" which has water bridges with O(Pro4) and O(PheS)
`during 31 % and 22% of the simulation, respectively. A water
`bridge between O(Ala2) and the imidazole ring of His'7 also
`exists 38% of the time during the first 200 ps, but it is rare
`in the remaining 340 ps. Finally, there are no water bridges
`involving TyrS2 and 0(Pro4) or O(Ala3), in contrast to the
`twisted conformer.
`Free Energy Calculations. The structures determined for
`both the els and twisted complexes seem reasonable from the
`viewpoints of stability, interactions, and function. Never·
`thcless, doubt remains about whether or not they are the real
`conformations. Comparison of total potential energies dem·
`onstrates that the twisted form is slightly lower in energy than
`the cis, in good agreement with the proposed stabilization of
`the transition state by the enzyme, but the difference (around
`7 kcal/mol) is not significant considering the statistical noise
`in the simulations (±70 kcal/mo!). Additional MD calcu(cid:173)
`lations, graphical manipulation, and simulated annealing
`procedures support the correctness of the structures, but it is
`obvious that more quantitative results are desirable. Though
`an e;ii;perimental 3-D structure of the FKBP-peptide complex
`is not available, attempts could be made to reproduce kinetic
`data for the isomerization catalyzed by the enzyme. One
`possibility was to compute the potential of mean force (PMF)
`for rotation a bout the Ala3-Pro4 peptidic bond, and to compare
`the 6G of this process with the observed AG of activation for
`the enzymatic reaction (AG'). Unfortunately, several at·
`tempted PMF calculations using holonomic constrains en·
`countered major technical difficulties. Development of
`alternative procedures for such perturbations is under con·
`sideration,
`However, some support can be sought by comparison of the
`relative AG* of peptides with different sequence. Park et al.
`( 1992) found a difference in keat favoring Ala over Gly at the
`
`Pl position in the Suc-Ala-X·Pro·Phe-pNA peptide. Their
`kcat ratio of 1200 (T = 278 K) translates to a lower 6G 1 for
`theAla(Pl) peptide by 3.9 kcal/mo!. Harrison &Stein ( 1992)
`reported a ke1.1/Km ratio for Ala and Gly peptides of 44 (T
`= 283 K), which considering the Km for these peptides (Park
`et al., 1992) translates to a lowering of AG' for the Ala(Pl)
`peptide by 2.7 kcal/mo!. Finally Albers et al. (1990) found
`a k.,. ratio between Ala(PI) and Giy(Pl) peptides of 12,
`which considering the Km values of Park ct al. (1992) yields
`a difference in AG' of 1.9 kcal/mo! (T = 278 K) favoring

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket